Mollugin Prevents Clp-Induced Sepsis in Mice by Inhibiting Tak1-Nf-Κb/Mapks Pathways and Activating Keap1-Nrf2 Pathway in Macrophages

46 Pages Posted: 27 Jun 2023

See all articles by Yi Wang

Yi Wang

Sichuan University - Department of Pathophysiology

Xiaojun Liu

Sichuan University

Xiaofei Shen

Chengdu University of Traditional Chinese Medicine

Han Wan

Sichuan University - Department of Pathophysiology

Jiayi Wang

Sichuan University

Yan-Ling Ren

Sichuan University - Department of Pathophysiology

Min Zhang

Sichuan University

Sixu Li

Sichuan University

Lijuan Guo

Sichuan University

Jingyu Li

Sichuan University

Abstract

Sepsis is a life-threatening organ dysfunction associated with macrophage overactivation. Targeted therapy against macrophages is considered a promising strategy for sepsis treatment. MLG, a compound extracted from traditional Chinese medicine Rubia cordifolia L., possesses anti-tumor and anti-inflammatory activities. This study aimed to investigate the anti-inflammatory effects and mechanisms of MLG in macrophages and its therapeutic role in CLP-induced sepsis in mice. The results demonstrated that MLG downregulated the inflammatory response induced by LPS or tumor necrosis factor α (TNF-α) in macrophages. Mechanistically, MLG suppressed the phosphorylation of TAK1, the upstream modulator of IKKα/β and MAPKs, thereby inhibiting the pro-inflammatory signaling transduction of NF-κB and MAPKs. Additionally, MLG also activated the Nrf2 antioxidant pathway, reducing intracellular reactive oxygen species. CETSA and molecular docking analyses revealed that MLG could effectively bind to TAK1 and Keap1, which may be involved in the inhibition of TAK1- NF-κB/MAPKs and activation of Nrf2 mediated by MLG. Animal study demonstrated that MLG ameliorated inflammatory injury of lung and liver in CLP-induced sepsis mice probably by reducing the levels of pro-inflammatory cytokines. Therefore, our study suggests that bi-directional roles of MLG in improving sepsis via blocking the TAK1-NF-κB/MAPKs and activating Nrf2 pathways, indicating its potential as a promising candidate drug for sepsis treatment.

Note:
Funding Declaration: Financial support was provided by The Science and Technology Bureau Fund of Sichuan Province (2021YFS0051 to Y.W).

Conflicts of Interest: None

Ethical Approval: All experimental procedures were approved by the Animal Welfare and Utilization Committee of Sichuan University.

Keywords: Mollugin, Anti-inflammatory effect, Macrophages, sepsis, TAK1-NF-κB /MAPKs pathway, Keap1-Nrf2 signaling

Suggested Citation

Wang, Yi and Liu, Xiaojun and Shen, Xiaofei and Wan, Han and Wang, Jiayi and Ren, Yan-Ling and Zhang, Min and Li, Sixu and Guo, Lijuan and Li, Jingyu, Mollugin Prevents Clp-Induced Sepsis in Mice by Inhibiting Tak1-Nf-Κb/Mapks Pathways and Activating Keap1-Nrf2 Pathway in Macrophages. Available at SSRN: https://ssrn.com/abstract=4479588 or http://dx.doi.org/10.2139/ssrn.4479588

Yi Wang (Contact Author)

Sichuan University - Department of Pathophysiology ( email )

Xiaojun Liu

Sichuan University ( email )

No. 24 South Section1, Yihuan Road,
Chengdu, 610064
China

Xiaofei Shen

Chengdu University of Traditional Chinese Medicine ( email )

China

Han Wan

Sichuan University - Department of Pathophysiology ( email )

Jiayi Wang

Sichuan University ( email )

No. 24 South Section1, Yihuan Road,
Chengdu, 610064
China

Yan-Ling Ren

Sichuan University - Department of Pathophysiology ( email )

Min Zhang

Sichuan University ( email )

No. 24 South Section1, Yihuan Road,
Chengdu, 610064
China

Sixu Li

Sichuan University ( email )

No. 24 South Section1, Yihuan Road,
Chengdu, 610064
China

Lijuan Guo

Sichuan University ( email )

No. 24 South Section1, Yihuan Road,
Chengdu, 610064
China

Jingyu Li

Sichuan University ( email )

No. 24 South Section1, Yihuan Road,
Chengdu, 610064
China

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
27
Abstract Views
225
PlumX Metrics